This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For We
BioMarin Seeks to Strengthen Market Position in Rare Bone Disease Treatment - BioMarin Pharmaceutical (NA
Zacks.com featured highlights include BioMarin Pharmaceutical, Invesco, Centene Corporation, Hewlett Packard Enterprise and Gibraltar Industries